American Society of Clinical Oncology

SHERPA: White

People

  1. Ginsberg
    Ginsberg
  2. Schwartz
    Schwartz
  3. Feldman
    Feldman
  4. Motzer
    Motzer
  5. Antonescu
    Antonescu
  6. Hudis
    Hudis
  7. Kris
    Kris
  8. Lake
    Lake
  9. Miller
    Miller
  10. Riely
    Riely

Groups

  1. Body Imaging Service (12)
  2. Department of Medicine (12)
  3. Radiology, Department of (12)
  4. Solid Tumor Oncology Division (11)
  5. Biostatistics Service (9)
  6. Epidemiology and Biostatistics (9)
  7. Genitourinary Oncology Service (5)
  8. GSK Faculty (4)
  9. Breast Medicine Service (3)
  10. Center for Pancreatic Cancer Research (3)
Search Within
  1. "Body Imaging Service"
  2. "2009"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (6)
Groups
  1. Body Imaging Service (12)
  2. Department of Medicine (12)
  3. Radiology, Department of (12)
  4. Solid Tumor Oncology Division (11)
  5. Biostatistics Service (9)
  6. Epidemiology and Biostatistics (9)

More Groups

People
  1. Lawrence Schwartz (4)
  2. Michelle Ginsberg (4)
  3. Sujata Patil (4)
  4. Darren Feldman (3)
  5. Nicole Leoce (3)
  6. Robert Motzer (3)

More People

Years
  1. 2009 (12)
Publications
  1. Journal of Clinical Oncology (12)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety of a novel capecitabine dosing schedule when combined with lapatinib in patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Modi, S.; Fornier, M.; Lake, D.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Treatment outcome and survival for patients (pts) with sarcomatoid-variant metastatic renal cell carcinoma (RCC): Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Molina, A. M.; Tickoo, S. K.; Ishill, N.; Trinos, M. J.; Schwartz, L. H.; Russo, P.; Feldman, D. R.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I trial of RAD001 (everolimus) plus sunitinib in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Kroog, G. S.; Feldman, D. R.; Kondagunta, G. V.; Ginsberg, M. S.; Fischer, P. M.; Trinos, M. J.; Patil, S.; Ishill, N. M.; Motzer, R. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase II trial of salirasib in patients with stage IIIB/IV lung adenocarcinoma enriched for KRAS mutations
    Meeting Abstract

    Johnson, M. L.; Rizvi, N. A.; Ginsberg, M. S.; Miller, V. A.; Kris, M. G.; Pao, W.; Riely, G. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT
    Meeting Abstract

    Carvajal, R. D.; Chapman, P. B.; Wolchok, J. D.; Cane, L.; Teitcher, J. B.; Lutzky, J.; Pavlick, A. C.; Bastian, B. C.; Antonescu, C. R.; Schwartz, G. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Randomized phase II trial of nanoparticle albumin-bound paclitaxel in three dosing schedules with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (MBC)
    Meeting Abstract

    Conlin, A. K.; Hudis, C. A.; Bach, A.; Moynahan, M.; Lake, D.; Forero-Torres, A.; Wright, G.; Hackney, M.; Clawson, A.; Seidman, A. D.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies
    Journal Article

    O'Connor, O. A.; Horwitz, S.; Hamlin, P.; Portlock, C.; Moskowitz, C. H.; Sarasohn, D.; Neylon, E.; Mastrella, J.; Hamelers, R.; Macgregor-Cortelli, B.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer
    Journal Article

    Morris, M. J.; Pandit-Taskar, N.; Carrasquillo, J.; Divgi, C. R.; Slovin, S.; Kelly, W. K.; Rathkopf, D.; Gignac, G. A.; Solit, D.; Schwartz, L.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II study of sorafenib in patients with metastatic or recurrent sarcomas
    Journal Article

    Maki, R. G.; D'adamo, D. R.; Keohan, M. L.; Saulle, M.; Schuetze, S. M.; Undevia, S. D.; Livingston, M. B.; Cooney, M. M.; Hensley, M. L.; Mita, M. M.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer
    Journal Article

    Riely, G. J.; Rizvi, N. A.; Kris, M. G.; Milton, D. T.; Solit, D. B.; Rosen, N.; Senturk, E.; Azzoli, C. G.; Brahmer, J. R.; Sirotnak, F. M.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save